{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:02:33Z","timestamp":1768582953276,"version":"3.49.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.it.2012.01.009","type":"journal-article","created":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T22:02:07Z","timestamp":1329602527000},"page":"357-363","source":"Crossref","is-referenced-by-count":51,"title":["Regulation of hematopoietic stem cell fate by the ubiquitin proteasome system"],"prefix":"10.1016","volume":"33","author":[{"given":"Kelly","family":"Moran-Crusio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linsey B.","family":"Reavie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iannis","family":"Aifantis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2012.01.009_bib0005","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.01.009_bib0010","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1242\/dev.02568","article-title":"The journey of developing hematopoietic stem cells","volume":"133","author":"Mikkola","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.it.2012.01.009_bib0015","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/nature04956","article-title":"Asymmetric and symmetric stem-cell divisions in development and cancer","volume":"441","author":"Morrison","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.01.009_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri1779","article-title":"Bone-marrow haematopoietic-stem-cell niches","volume":"6","author":"Wilson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2012.01.009_bib0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4161\/cc.7.5.5549","article-title":"Leukemia and hematopoietic stem cells: balancing proliferation and quiescence","volume":"7","author":"Jude","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.it.2012.01.009_bib0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/wsbm.145","article-title":"Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies","volume":"3","author":"Warr","year":"2011","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.it.2012.01.009_bib0035","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the haematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.01.009_bib0040","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.immuni.2006.11.005","article-title":"Maintaining hematopoietic stem cells in the vascular niche","volume":"25","author":"Kiel","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.it.2012.01.009_bib0045","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nature02041","article-title":"Identification of the haematopoietic stem cell niche and control of the niche size","volume":"425","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.01.009_bib0050","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1073\/pnas.0701152104","article-title":"Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia","volume":"104","author":"Parmar","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2012.01.009_bib0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri2726","article-title":"Awakening dormant haematopoietic stem cells","volume":"10","author":"Trumpp","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2012.01.009_bib0060","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/blood-2009-01-201384","article-title":"Scl regulates the quiescence and the long-term competence of hematopoietic stem cells","volume":"115","author":"Lacombe","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.01.009_bib0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.stem.2008.09.005","article-title":"Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity","volume":"3","author":"Laurenti","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.it.2012.01.009_bib0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature01572","article-title":"Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells","volume":"423","author":"Lessard","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.01.009_bib0075","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1242\/dev.126.11.2563","article-title":"Cbfa2 is required for the formation of intra-aortic hematopoietic clusters","volume":"126","author":"North","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.it.2012.01.009_bib0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01587","article-title":"Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells","volume":"423","author":"Park","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.01.009_bib0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ni.1839","article-title":"Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex","volume":"11","author":"Reavie","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2012.01.009_bib0090","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.93.8.3444","article-title":"Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis","volume":"93","author":"Wang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2012.01.009_bib0095","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.313104","article-title":"c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation","volume":"18","author":"Wilson","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.it.2012.01.009_bib0100","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gad.1621808","article-title":"Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL","volume":"22","author":"Matsuoka","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.it.2012.01.009_bib0105","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.20080277","article-title":"Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7","volume":"205","author":"Thompson","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2012.01.009_bib0110","doi-asserted-by":"crossref","first-page":"20643","DOI":"10.1074\/jbc.M602461200","article-title":"Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2012.01.009_bib0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbagrm.2010.11.006","article-title":"Proteolytic and non-proteolytic roles of ubiquitin and the ubiquitin proteasome system in transcriptional regulation","volume":"1809","author":"Bhat","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.it.2012.01.009_bib0120","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.4161\/cc.9.16.12551","article-title":"Roles of the ubiquitin-proteosome system in neurogenesis","volume":"9","author":"Tuoc","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.it.2012.01.009_bib0125","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"Rubinsztein","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.01.009_bib0130","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrc1994","article-title":"Ubiquitin and ubiquitin-like proteins in cancer pathogenesis","volume":"6","author":"Hoeller","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.it.2012.01.009_bib0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2004.09.019","article-title":"Ubiquitin: structures, functions, mechanisms","volume":"1695","author":"Pickart","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.it.2012.01.009_bib0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1126\/science.1127085","article-title":"Proteasome-independent functions of ubiquitin in endocytosis and signaling","volume":"315","author":"Mukhopadhyay","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.it.2012.01.009_bib0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ceb.2008.01.012","article-title":"Reverse the curse--the role of deubiquitination in cell cycle control","volume":"20","author":"Song","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.it.2012.01.009_bib0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ccr.2008.06.001","article-title":"The HECT family of E3 ubiquitin ligases: multiple players in cancer development","volume":"14","author":"Bernassola","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.01.009_bib0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrc1881","article-title":"Ubiquitin ligases: cell-cycle control and cancer","volume":"6","author":"Nakayama","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.it.2012.01.009_bib0160","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1634\/theoncologist.8-6-508","article-title":"Velcade: U. S. FDA approval for the treatment of multiple myeloma progressing on prior therapy","volume":"8","author":"Kane","year":"2003","journal-title":"Oncologist"},{"issue":"18 Pt 1","key":"10.1016\/j.it.2012.01.009_bib0165","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1158\/1078-0432.CCR-07-0871","article-title":"Bortezomib for the treatment of mantle cell lymphoma","volume":"13","author":"Kane","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.it.2012.01.009_bib0170","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature07960","article-title":"Targeting the ubiquitin system in cancer therapy","volume":"458","author":"Hoeller","year":"2009","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.it.2012.01.009_bib0175","doi-asserted-by":"crossref","first-page":"pS7","DOI":"10.1186\/1471-2091-9-S1-S7","article-title":"The ubiquitin system, disease, and drug discovery","volume":"9","author":"Petroski","year":"2008","journal-title":"BMC Biochem."},{"key":"10.1016\/j.it.2012.01.009_bib0180","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nbt.1645","article-title":"Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase","volume":"28","author":"Aghajan","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.it.2012.01.009_bib0185","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nbt.1646","article-title":"An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase","volume":"28","author":"Orlicky","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.it.2012.01.009_bib0190","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nchembio.2007.43","article-title":"Mechanisms, biology and inhibitors of deubiquitinating enzymes","volume":"3","author":"Love","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.it.2012.01.009_bib0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival","volume":"463","author":"Schwickart","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.01.009_bib0200","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1073\/pnas.86.4.1168","article-title":"v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas","volume":"86","author":"Langdon","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2012.01.009_bib0205","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nrm1762","article-title":"The Cbl interactome and its functions","volume":"6","author":"Schmidt","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.it.2012.01.009_bib0210","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/en.2002-220374","article-title":"c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription","volume":"143","author":"Goh","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.it.2012.01.009_bib0215","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1074\/jbc.M108552200","article-title":"c-Cbl binding and ubiquitin-dependent lysosomal degradation of membrane-associated Notch1","volume":"277","author":"Jehn","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2012.01.009_bib0220","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2004-05-1768","article-title":"Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b\/c-Cbl)","volume":"105","author":"Zeng","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.01.009_bib0225","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1101\/gad.1651408","article-title":"The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells","volume":"22","author":"Rathinam","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.it.2012.01.009_bib0230","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1182\/blood-2008-09-181107","article-title":"Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement","volume":"113","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.01.009_bib0235","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2010.09.008","article-title":"Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling","volume":"18","author":"Rathinam","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.01.009_bib0240","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00277-010-0920-6","article-title":"Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies","volume":"89","author":"Bacher","year":"2010","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.it.2012.01.009_bib0245","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.leukres.2010.07.004","article-title":"Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML","volume":"34","author":"Barresi","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.it.2012.01.009_bib0250","doi-asserted-by":"crossref","first-page":"32596","DOI":"10.1074\/jbc.M110.106161","article-title":"Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism","volume":"285","author":"Fernandes","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2012.01.009_bib0255","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1471-2407-10-401","article-title":"Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias","volume":"10","author":"Rocquain","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.it.2012.01.009_bib0260","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/leu.2010.69","article-title":"Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1","volume":"24","author":"Tefferi","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2012.01.009_bib0265","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ni.2021","article-title":"The E3 ligase Itch is a negative regulator of the homeostasis and function of hematopoietic stem cells","volume":"12","author":"Rathinam","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2012.01.009_bib0270","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1073\/pnas.0307875101","article-title":"Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein","volume":"101","author":"Tetzlaff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2012.01.009_bib0275","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1074\/jbc.M312337200","article-title":"Mouse Fbw7\/Sel-10\/Cdc4 is required for notch degradation during vascular development","volume":"279","author":"Tsunematsu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2012.01.009_bib0280","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1084\/jem.20062299","article-title":"Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis","volume":"204","author":"Onoyama","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2012.01.009_bib0285","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","article-title":"The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer","volume":"8","author":"Kaelin","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.it.2012.01.009_bib0290","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrm2354","article-title":"The role of oxygen availability in embryonic development and stem cell function","volume":"9","author":"Simon","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.it.2012.01.009_bib0295","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.stem.2010.06.020","article-title":"Regulation of the HIF-1alpha level is essential for hematopoietic stem cells","volume":"7","author":"Takubo","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.it.2012.01.009_bib0300","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2005.01.008","article-title":"The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway","volume":"17","author":"Nijman","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.it.2012.01.009_bib0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc970","article-title":"The Fanconi anaemia\/BRCA pathway","volume":"3","author":"D\u2019Andrea","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.it.2012.01.009_bib0310","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/35076590","article-title":"The emerging genetic and molecular basis of Fanconi anaemia","volume":"2","author":"Joenje","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.it.2012.01.009_bib0315","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.devcel.2009.01.001","article-title":"Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype","volume":"16","author":"Kim","year":"2009","journal-title":"Dev. Cell"},{"key":"10.1016\/j.it.2012.01.009_bib0320","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/stem.437","article-title":"Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1","volume":"28","author":"Parmar","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.it.2012.01.009_bib0325","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1101\/gad.10.9.1054","article-title":"p53: puzzle and paradigm","volume":"10","author":"Ko","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.it.2012.01.009_bib0330","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nrd2656","article-title":"The genetics of the p53 pathway, apoptosis and cancer therapy","volume":"7","author":"Vazquez","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.it.2012.01.009_bib0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","article-title":"Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53","volume":"420","author":"Honda","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.it.2012.01.009_bib0340","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/378206a0","article-title":"Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53","volume":"378","author":"Jones","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.01.009_bib0345","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/378203a0","article-title":"Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53","volume":"378","author":"Montes de Oca Luna","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.01.009_bib0350","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.cdd.4401912","article-title":"Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4","volume":"13","author":"Marine","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.it.2012.01.009_bib0355","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/cdd.2009.77","article-title":"The multiple levels of regulation by p53 ubiquitination","volume":"17","author":"Lee","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.it.2012.01.009_bib0360","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrm3173","article-title":"The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation","volume":"12","author":"Weissman","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.it.2012.01.009_bib0365","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/MCB.16.9.4952","article-title":"Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function","volume":"16","author":"Ludwig","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.it.2012.01.009_bib0370","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/j.1460-2075.1996.tb00418.x","article-title":"Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant","volume":"15","author":"Rowan","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.it.2012.01.009_bib0375","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stem.2010.09.013","article-title":"Mdm2 is required for survival of hematopoietic stem cells\/progenitors via dampening of ROS-induced p53 activity","volume":"7","author":"Abbas","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.it.2012.01.009_bib0380","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.2898810","article-title":"Purification and characterization of mouse hematopoietic stem cells","volume":"241","author":"Spangrude","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.it.2012.01.009_bib0385","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.273.5272.242","article-title":"Long-term lymphohematopoietic reconstitution by a single CD34-low\/negative hematopoietic stem cell","volume":"273","author":"Osawa","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.it.2012.01.009_bib0390","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2005.05.026","article-title":"SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells","volume":"121","author":"Kiel","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.01.009_bib0395","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","article-title":"Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair","volume":"135","author":"Wilson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.01.009_bib0400","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.pharmtox.051208.165340","article-title":"Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology","volume":"49","author":"Schwartz","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.it.2012.01.009_bib0405","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35056563","article-title":"Themes and variations on ubiquitylation","volume":"2","author":"Weissman","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.it.2012.01.009_bib0410","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrm2690","article-title":"Physiological functions of the HECT family of ubiquitin ligases","volume":"10","author":"Rotin","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.it.2012.01.009_bib0415","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrc3120","article-title":"RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis","volume":"11","author":"Lipkowitz","year":"2011","journal-title":"Nat. Rev. Cancer"}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490612000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490612000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T22:40:40Z","timestamp":1640817640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490612000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1471490612000105"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2012.01.009","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}